237 results on '"Nakamatsu, Kiyoshi"'
Search Results
2. External beam radiotherapy combination is a risk factor for bladder cancer in patients with prostate cancer treated with brachytherapy
3. Difference in failure patterns after stereotactic body radiotherapy for lung cancer according to clinical T stage based on 4D computed tomography
4. Visualization of tumor hypoxia and re-oxygenation after stereotactic body radiation therapy in early peripheral lung cancer: A prospective study
5. Impact of rectal gas on the planning target volume margin for pelvic bone and prostate matching in prostate cancer patients receiving volumetric-modulated arc therapy
6. Multi-institutional feasibility study of intensity-modulated radiotherapy with chemotherapy for locally advanced non-small cell lung cancer
7. Multi-institution model (big model) versus single-institution model of knowledge-based volumetric modulated arc therapy (VMAT) planning for prostate cancer
8. Risk factors for radiation pneumonitis after rotating gantry intensity-modulated radiation therapy for lung cancer
9. Difference in VMAT dose distribution for prostate cancer with/without rectal gas removal and/or adaptive replanning
10. Radiation-Induced Lymphopenia and Its Impact on Survival in Patients with Brain Metastasis.
11. Incidence and Risk Factors of Symptomatic Radiation Pneumonitis in Non–Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy and Consolidation Durvalumab
12. Outcome of chemoradiotherapy using intensity-modulated radiation therapy for cervical esophageal cancer: a single institute experience
13. Dosimetric evaluation with knowledge-based planning created at different periods in volumetric-modulated arc therapy for prostate cancer: a multi-institution study
14. Comparison of patient-specific intensity modulated radiation therapy quality assurance for the prostate across multiple institutions
15. Comparing the 7th and 8th editions of the American Joint Committee on Cancer/Union for International Cancer Control TNM staging system for esophageal squamous cell carcinoma treated by definitive radiotherapy
16. Stereotactic body radiotherapy in patients with chronic obstructive pulmonary disease and interstitial pneumonia: a review
17. Definitive chemoradiotherapy for anal canal cancer: single-center experience
18. Additive Effects of Radiation and Docetaxel on Murine SCCVII Tumors In Vivo: Special Reference to Changes in the Cell Cycle
19. Dosimetric evaluation of simplified knowledge-based plan with an extensive stepping validation approach in volumetric-modulated arc therapy-stereotactic body radiotherapy for lung cancer
20. Difference in failure patterns after stereotactic body radiotherapy for lung cancer according to clinical T stage based on 4D computed tomography
21. Impact of Knowledge-based Plan Model Improvement on Plan Complexity and Deliverability in VMAT For Prostate Cancer: A Multi-institutional Study
22. Clinical outcomes of IMRT planned with or without PET/CT simulation for patients with pharyngeal cancers
23. Influence of cleaned-up commercial knowledge-based treatment planning on volumetric-modulated arc therapy of prostate cancer
24. Investigation into the Optimal Strategy of Radium-223 Therapy for Metastatic Castration-Resistant Prostate Cancer
25. Mechanical performance of a commercial knowledge-based VMAT planning for prostate cancer
26. Evaluation of multiple institutions’ models for knowledge-based planning of volumetric modulated arc therapy (VMAT) for prostate cancer
27. Recurrence patterns and progression-free survival after chemoradiotherapy with or without consolidation durvalumab for stage III non-small cell lung cancer.
28. Clinical results of definitive-dose (50 Gy/25 fractions) preoperative chemoradiotherapy for unresectable esophageal cancer
29. Escalated Maximum Dose in the Planning Target Volume Improves Local Control in Stereotactic Body Radiation Therapy for T1-2 Lung Cancer
30. Efficacy of silodosin in patients undergoing brachytherapy: a randomized trial involving a pressure flow study
31. Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non–small-cell Lung Cancer: SQUAT trial (WJOG 12119L)
32. Difference in VMAT dose distribution for prostate cancer with/without rectal gas removal and/or adaptive replanning
33. Radiation Treatment Planning Using Positron Emission and Computed Tomography for Lung and Pharyngeal Cancers: A Multiple-Threshold Method for [ 18F]Fluoro-2-Deoxyglucose Activity
34. An updating approach for knowledge‐based planning models to improve plan quality and variability in volumetric‐modulated arc therapy for prostate cancer
35. Serum lactate dehydrogenase is a predictive biomarker in patients with oropharyngeal cancer undergoing radiotherapy: Retrospective study on predictive factors
36. A randomized phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer: Short-term infusion versus protracted infusion chemotherapy (KROSG0101/JROSG021)
37. Randomized Clinical Trial of Postoperative Strontium-90 Radiation Therapy for Pterygia: Treatment Using 30 Gy/3 Fractions vs. 40 Gy/4 Fractions
38. A Phase I Study of Split-dose Cisplatin and Etoposide with Concurrent Accelerated Hyperfractionated Thoracic Radiotherapy in Elderly Patients with Limited-disease Small Cell Lung Cancer
39. Static and moving phantom studies for radiation treatment planning in a positron emission tomography and computed tomography (PET/CT) system
40. Treatment outcomes and dose-volume histogram analysis of simultaneous integrated boost method for malignant gliomas using intensity-modulated radiotherapy
41. Impact of Aperture Shape Controller on Knowledge-based VMAT Planning of Prostate Cancer
42. Comparison of outcomes between overlapping structure-based and non-overlapping structure-based optimization for simultaneous integrated boost IMRT for malignant gliomas
43. Erythropoietin/Erythropoietin-receptor system as an angiogenic factor in chemically induced murine hepatic tumors
44. Analysis of interfractional set-up errors and intrafractional organ motions during IMRT for head and neck tumors to define an appropriate planning target volume (PTV)- and planning organs at risk volume (PRV)-margins
45. Long-term Follow-up of a Randomized Phase II Study of Cisplatin/5-FU Concurrent Chemoradiotherapy for Esophageal Cancer (KROSG0101/JROSG021)
46. Experimental Animal Model of Re-irradiation to Evaluate Radiation-induced Damage in the Normal Intestine
47. Influence of cleaned-up commercial knowledge-based treatment planning on volumetric-modulated arc therapy of prostate cancer
48. Dose-volume Histogram Analysis of Knowledge-based Volumetric-modulated Arc Therapy Planning in Postoperative Breast Cancer Irradiation
49. Definitive Radiation Therapy for Moderately Advanced Laryngeal Cancer: Effects of Accelerated Hyperfractionation
50. A Two-step Intensity-modulated Radiation Therapy Method for Nasopharyngeal Cancer: The Kinki University Experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.